Abiopharma

🔍 Cogan Jeremy (Executive)

Company: Movano Inc. (MOVE)

Report Date: 2026-01-05

Detailed Transactions and Holdings:

• Acquired 20,000 shares of Common Stock at $1.25 per share (Direct)
  Date: 2026-01-05 | Code: M | equity_swap_involved: false | shares_owned_after: 25,204.00 | transaction_form_type: 4
• Sold 1,879 shares of Common Stock at $8.35 per share (Direct)
  Date: 2026-01-05 | Code: S | equity_swap_involved: false | shares_owned_after: 23,325.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 3,859 shares of Common Stock at $8.03 per share (Direct)
  Date: 2026-01-06 | Code: S | equity_swap_involved: false | shares_owned_after: 19,466.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 4,359 shares of Common Stock at $7.57 per share (Direct)
  Date: 2026-01-06 | Code: S | equity_swap_involved: false | shares_owned_after: 15,107.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Acquired 9,299 shares of Common Stock (Direct)
  Date: 2026-01-09 | Code: A | equity_swap_involved: false | shares_owned_after: 24,406.00 | transaction_form_type: 4 | Footnotes: F5
• Sold 20,000 shares of Stock Options (Right to Buy) at $1.25 per share (Derivative)
  Date: 2026-01-05 | Code: M | Expires: 2026-03-15 | equity_swap_involved: false | shares_owned_after: 64,834.00 | transaction_form_type: 4 | Footnotes: F6

Footnotes:

• F1: Represents shares sold to pay withholding taxes and exercise prices due in connection with the exercise of stock option awards granted to the reporting person in lieu of cash salary during 2025.
• F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.00 to $8.61, inclusive. The reporting person undertakes to provide to Movano Inc., any security holder of Movano Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
• F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $8.35, inclusive. The reporting person undertakes to provide to Movano Inc., any security holder of Movano Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
• F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.90, inclusive. The reporting person undertakes to provide to Movano Inc., any security holder of Movano Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
• F5: The reported transaction involved the reporting person's receipt of a grant of restricted stock units ("RSUs") under the Company's Omnibus Incentive Plan in lieu of salary for the period January 1, 2026 to Mach 31, 2026.
• F6: This option award was granted contingent upon shareholder approval of an amendment to the Omnibus Incentive Plan that increases the number of shares of Common Stock authorized for issuance under the Plan (the "Plan Amendment"). The option became exerciseable upon shareholder approval of the Plan Amendment on December 16, 2025.